olympia semaglutide reviews Pharmacy | 503A Compounding Pharmacy — & Licensing GLP-1 Agonists for Weight Loss

According to FDA prescribing information, nausea affects approximately 44% of patients on Wegovy (weight management dose), while vomiting, diarrhea, constipation, and abdominal pain are also common, particularly during dose escalation

Never use semaglutide beyond the printed expiration date on your specific vial or pen, even if the medication appears clear and unchanged

No callback came either time

This information should be interpreted with a qualified healthcare provider to support more tailored treatment planning and dosing discussions

Simultaneously, these agents suppress glucagon secretion, a hormone that raises blood sugar levels